X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (28) 28
female (22) 22
humans (21) 21
adult (20) 20
middle aged (20) 20
aged (18) 18
prognosis (17) 17
index medicus (13) 13
retrospective studies (13) 13
male (12) 12
neoplasm staging (11) 11
survival (11) 11
survival rate (11) 11
breast cancer (10) 10
follow-up studies (10) 10
cancer (8) 8
breast neoplasms - pathology (7) 7
chemotherapy (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast neoplasms - mortality (6) 6
carcinoma (6) 6
metastasis (6) 6
therapy (6) 6
adenocarcinoma - drug therapy (5) 5
aged, 80 and over (5) 5
disease-free survival (5) 5
receptor, erbb-2 - metabolism (5) 5
risk factors (5) 5
stomach neoplasms - pathology (5) 5
adenocarcinoma - secondary (4) 4
analysis (4) 4
breast neoplasms - drug therapy (4) 4
cancer research (4) 4
carcinoma, ductal, breast - mortality (4) 4
carcinoma, lobular - mortality (4) 4
care and treatment (4) 4
cisplatin (4) 4
cisplatin - administration & dosage (4) 4
colorectal-cancer (4) 4
diagnosis (4) 4
fluorouracil (4) 4
neoplasm metastasis (4) 4
neutrophils - pathology (4) 4
oxaliplatin (4) 4
phase-ii (4) 4
receptors, estrogen - metabolism (4) 4
receptors, progesterone - metabolism (4) 4
risk (4) 4
stomach neoplasms - drug therapy (4) 4
treatment outcome (4) 4
turkey (4) 4
5-fluorouracil (3) 3
adenocarcinoma (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
biomedicine (3) 3
camptothecin - analogs & derivatives (3) 3
cancer patients (3) 3
carcinoma, ductal, breast - secondary (3) 3
carcinoma, lobular - secondary (3) 3
combination (3) 3
combination chemotherapy (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
expression (3) 3
female genital diseases and pregnancy complications (3) 3
fluorouracil - administration & dosage (3) 3
follow-up (3) 3
health aspects (3) 3
immunoenzyme techniques (3) 3
immunohistochemistry (3) 3
irinotecan (3) 3
leucovorin - administration & dosage (3) 3
lymphatic metastasis (3) 3
lymphocytes - pathology (3) 3
metastatic gastric cancer (3) 3
neoplasm grading (3) 3
neoplasm invasiveness (3) 3
patients (3) 3
pharmacology & pharmacy (3) 3
surgery (3) 3
surgical oncology (3) 3
survival analysis (3) 3
time factors (3) 3
toxicity (3) 3
trial (3) 3
tumor (3) 3
young adult (3) 3
adenocarcinoma - mortality (2) 2
adenocarcinoma - pathology (2) 2
adenocarcinoma, mucinous - mortality (2) 2
adenocarcinoma, mucinous - secondary (2) 2
administration, oral (2) 2
antineoplastic agents - administration & dosage (2) 2
bevacizumab (2) 2
biomarkers, tumor - metabolism (2) 2
biomedicine general (2) 2
brain metastases (2) 2
brain neoplasms - mortality (2) 2
brain neoplasms - secondary (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Clinical & Experimental Metastasis, ISSN 0262-0898, 12/2013, Volume 30, Issue 8, pp. 1047 - 1062
This study aimed to investigate the prognostic and predictive effect of FOXP3+ Tregs together with clinicopathologic factors in locally advanced breast cancer... 
Neoadjuvant chemotherapy | Biomedicine | Hematology | Pathologic complete response | Cancer Research | Oncology | Breast cancer | Surgical Oncology | Biomedicine general | FOXP3+ T lymphocytes | IMMUNE-RESPONSE | FOXP3+T lymphocytes | CYCLOPHOSPHAMIDE | DOXORUBICIN | TUMOR | PATHOLOGICAL COMPLETE RESPONSE | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | NEOADJUVANT-CHEMOTHERAPY | REGULATORY T-CELLS | EXPRESSION | LYMPHOCYTE INFILTRATION | Carcinoma, Papillary - immunology | Receptors, Estrogen - metabolism | Prognosis | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Carcinoma, Ductal, Breast - immunology | Receptor, ErbB-2 - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Carcinoma, Papillary - secondary | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | T-Lymphocytes, Regulatory - immunology | Carcinoma, Ductal, Breast - drug therapy | Neoplasm Grading | Forkhead Transcription Factors - metabolism | Axilla | Adult | Female | Neoadjuvant Therapy | Adenocarcinoma, Mucinous - drug therapy | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - immunology | Carcinoma, Lobular - secondary | Risk Factors | Carcinoma, Papillary - drug therapy | Survival Rate | Adenocarcinoma, Mucinous - secondary | Lymphatic Metastasis | Adenocarcinoma, Mucinous - immunology | Breast Neoplasms - drug therapy | Adenocarcinoma, Mucinous - mortality | Carcinoma, Papillary - mortality | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Chemotherapy | T cells | Analysis | Cancer
Journal Article
Journal Article
Journal of Cancer Research and Therapeutics, ISSN 0973-1482, 2018, Volume 14, Issue 12, pp. S1201 - S1208
Journal Article
Clinical & Experimental Metastasis, ISSN 0262-0898, 2/2013, Volume 30, Issue 2, pp. 201 - 213
We aimed to define the clinicopathologic characteristics of breast cancer (BC) patients with brain metastasis (BM) and to investigate the effect of these... 
Clinical outcome | Biomedicine | Hematology | Tumor subtypes | Cancer Research | Oncology | Breast cancer | Brain metastases | Surgical Oncology | Biomedicine general | PROGNOSTIC-FACTORS | TRASTUZUMAB | SUBTYPES | RELAPSE | NERVOUS-SYSTEM METASTASES | THERAPY | ONCOLOGY | EXPERIENCE | BONE | HER2 | CLINICAL-OUTCOMES | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Prognosis | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Neoplasm Recurrence, Local - pathology | Brain Neoplasms - secondary | Carcinoma, Lobular - therapy | Neoplasm Grading | Skin Neoplasms - mortality | Adult | Carcinoma, Ductal, Breast - pathology | Female | Retrospective Studies | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Carcinoma, Medullary - mortality | Skin Neoplasms - therapy | Neoplasm Invasiveness | Neoplasm Recurrence, Local - therapy | Carcinoma, Medullary - pathology | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Carcinoma, Medullary - therapy | Carcinoma, Ductal, Breast - therapy | Breast Neoplasms - pathology | Brain Neoplasms - therapy | Skin Neoplasms - secondary | Breast Neoplasms - mortality | Aged | Neoplasm Staging
Journal Article
Journal of B.U.ON, ISSN 1107-0625, 07/2018, Volume 23, Issue 4, pp. 862 - 866
BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repair processes and thus they are tumor suppressor genes.... 
BRCA | Breast cancer | DNA repair | Ovarian cancer | CANCER SYNDROMES | LOCALIZATION | ovarian cancer | PROPHYLACTIC OOPHORECTOMY SPECIMENS | MUTATION CARRIERS | DNA-DAMAGE | HEREDITARY BREAST | breast cancer | RISK | WOMEN | ONCOLOGY | GENETICS | EXPRESSION
Journal Article
Journal of cancer research and therapeutics, 12/2018, Volume 14, Issue Supplement, p. S1201
In this study, we investigated the expression of thyroid transcription factor-1 (TTF-1) in lung adenocarcinoma patients' samples and analyzed the association... 
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2014, Volume 15, Issue 12, pp. 4781 - 4786
Background: The purpose of this study was to analyze the predictive value of neutrophil/lymphocyte ratio (NLR) to better clarify which patient groups will... 
Response to therapy | Neutrophil to lymphocyte ratio | Metastatic colorectal cancer | Bevacizumab | 1ST-LINE TREATMENT | CONTROLLED-TRIAL | LEUCOVORIN | NEUTROPHIL | EFFICACY | neutrophil to lymphocyte ratio | OXALIPLATIN | FLUOROURACIL | response to therapy | LYMPHOCYTE RATIO | ONCOLOGY | bevacizumab | ORAL FLUOROPYRIMIDINES | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2013, Volume 14, Issue 3, pp. 2101 - 2105
Background: Long-term survival is a problem with locally advanced and metastatic renal cell carcinomas. Sunitinib malate is an oral multitargeted tyrosine... 
Metastatic renal cell carcinoma | Sunitinib | Hmatologic parameters | sunitinib | SURVIVAL | INTERFERON-ALPHA | SOLID TUMORS | GENE | ONCOLOGY | hematologic parameters | TUMOR-SUPPRESSOR | THROMBOCYTOSIS | INHIBITOR | CANCER
Journal Article
Asian Pacific journal of cancer prevention : APJCP, ISSN 1513-7368, 2013, Volume 14, Issue 10, pp. 6013 - 6017
Background: To evaluate the clinicopathologic and demographic characteristics of triple-negative breast cancer (TNBC) patients and to determine differences... 
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2013, Volume 14, Issue 6, pp. 3711 - 3717
Background: To assess the efficacy and tolerability of Cisplatin plus Gemcitabine combination in patients with brain metastases (BM) from breast cancer (BC).... 
Brain metastases | Breast cancer | Cisplatin plus gemcitabine | Triple negative | SURVIVAL | PROGNOSTIC-FACTORS | brain metastases | TREATMENT OUTCOMES | CHEMOTHERAPY | TRIAL | NERVOUS-SYSTEM METASTASES | THERAPY | cisplatin plus gemcitabine | ONCOLOGY | triple negative | SINGLE-AGENT GEMCITABINE | RADIOTHERAPY | CARCINOMA
Journal Article